Superworth

Tyra Biosciences EPS TYRA

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$2.40
Latest quarter, Q2 FY26
−$0.69
Fiscal year 2025
−$2.01

Tyra Biosciences' earnings per share was −$2.40 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.69.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.01n/a
FY2024−$1.51n/a
FY2023−$1.61n/a
FY2022−$1.33n/a
FY2021−$5.48n/a
FY2020n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.69n/a−$2.40
Q1 FY26−$0.64n/a−$2.18
Q4 FY25−$0.57n/a−$2.01
Q3 FY25−$0.50n/a−$1.87
Q2 FY25−$0.47n/a−$1.78
Q1 FY25−$0.47n/a−$1.63
Q4 FY24−$0.43n/a−$1.51
Q3 FY24−$0.41n/a−$1.61
Q2 FY24−$0.32n/a−$1.69
Q1 FY24−$0.35n/a−$1.68
Q4 FY23−$0.53n/a−$1.61
Q3 FY23−$0.49n/a−$1.39

Against its peers

Companies in Drug Manufacturers - General nearest Tyra Biosciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
TYRATyra Biosciences−$2.40
OMEROmeros$1.52
AMPHAmphastar Pharmaceuticals$1.70−36% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
HRMYHarmony Biosciences$3.09−0% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
Peer median$2.07

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Tyra Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.